Načítá se...
Treatment of Relapsed Acute Myeloid Leukemia
Relapse is still a common scenario in acute myeloid leukemia (AML) treatment and occurs in 40–50% of younger and the great majority of elderly patients. The prognosis in relapsed AML patients is generally poor but depends largely on the timing of relapse (early versus late) and the possibility of al...
Uloženo v:
| Vydáno v: | Curr Treat Options Oncol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer US
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7324428/ https://ncbi.nlm.nih.gov/pubmed/32601974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-020-00765-5 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|